Cellectis S.A. Interest Expense Income Net Defined Benefit Liability Asset
Cellectis S.A. (CLLS) reported Interest Expense Income Net Defined Benefit Liability Asset of $42.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset · last filed 2026-03-20
| Period end | Interest Expense Income Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2025-12-31 | $42.00K 20-F · filed 2026-03-20 |
| 2024-12-31 | $76.00K 20-F · filed 2026-03-20 |
| 2023-12-31 | $90.00K 20-F · filed 2026-03-20 |
| 2022-12-31 | $43.00K 20-F · filed 2025-03-14 |
| 2021-12-31 | $26.00K 20-F · filed 2024-04-29 |
| 2020-12-31 | $29.00K 20-F · filed 2023-03-14 |
| 2019-12-31 | $39.00K 20-F · filed 2022-03-03 |
| 2018-12-31 | $38.00K 20-F · filed 2021-03-04 |
| 2017-12-31 | $24.00K 20-F · filed 2020-03-05 |
| 2016-12-31 | $9.00K 20-F · filed 2019-03-12 |
| 2015-12-31 | $7.00K 20-F · filed 2018-03-13 |